These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 35992916)

  • 1. The value of 3D pseudo-continuousarterial spin labeling perfusion imaging in moyamoya disease-Comparison with dynamic susceptibility contrast perfusion imaging.
    Zhang H; Lu M; Liu S; Liu D; Shen X; Sheng F; Han C; Cai J
    Front Neurosci; 2022; 16():944246. PubMed ID: 35992916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical assessment of cerebral hemodynamics in Moyamoya disease via multiple inversion time arterial spin labeling and dynamic susceptibility contrast-magnetic resonance imaging: A comparative study.
    Qiao PG; Han C; Zuo ZW; Wang YT; Pfeuffer J; Duan L; Qian T; Li GJ
    J Neuroradiol; 2017 Jul; 44(4):273-280. PubMed ID: 28168990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor recurrence versus treatment effects in glioma: A comparative study of three dimensional pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging.
    Xu Q; Liu Q; Ge H; Ge X; Wu J; Qu J; Xu K
    Medicine (Baltimore); 2017 Dec; 96(50):e9332. PubMed ID: 29390403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of three-dimensional pseudo-continuous arterial spin labeling perfusion imaging with gradient-echo and spin-echo dynamic susceptibility contrast MRI.
    Wong AM; Yan FX; Liu HL
    J Magn Reson Imaging; 2014 Feb; 39(2):427-33. PubMed ID: 23677620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multi-parameter arterial spin labeling versus dynamic magnetic-sensitive enhanced cerebral perfusion imaging for diagnosis of transient cerebral ischemic attack].
    Xu Y; Lv JH; Ma L; Chen WJ; Lou X
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jun; 36(6):768-74. PubMed ID: 27320876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial spin-labeling cerebral perfusion changes after revascularization surgery in pediatric moyamoya disease and syndrome.
    Quon JL; Kim LH; Lober RM; Maleki M; Steinberg GK; Yeom KW
    J Neurosurg Pediatr; 2019 Apr; 23(4):486-492. PubMed ID: 30738390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of arterial spin labeling perfusion with dynamic susceptibility contrast perfusion in Moyamoya disease.
    Yadav N; Pendharkar H; Gupta AK; Prasad C; Shukla D; Kandavel T; Bansal S
    J Neurosci Rural Pract; 2023; 14(2):286-292. PubMed ID: 37181159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-delay arterial spin labeling perfusion MRI in moyamoya disease--comparison with CT perfusion imaging.
    Wang R; Yu S; Alger JR; Zuo Z; Chen J; Wang R; An J; Wang B; Zhao J; Xue R; Wang DJ
    Eur Radiol; 2014 May; 24(5):1135-44. PubMed ID: 24557051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-delay multi-parametric arterial spin-labeled perfusion MRI in acute ischemic stroke - Comparison with dynamic susceptibility contrast enhanced perfusion imaging.
    Wang DJ; Alger JR; Qiao JX; Gunther M; Pope WB; Saver JL; Salamon N; Liebeskind DS;
    Neuroimage Clin; 2013; 3():1-7. PubMed ID: 24159561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudo-continuous and territorial arterial spin labeling MRI for assessment of cerebral perfusion in moyamoya disease after revascularization: A comparative study with digital subtraction angiography.
    Li J; Meng Q; Huang L; Pylypenko D; Zhong H
    Heliyon; 2024 Sep; 10(17):e37368. PubMed ID: 39296041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-phase 3D arterial spin labeling brain MRI in assessing cerebral blood perfusion and arterial transit times in children at 3T.
    Hu HH; Rusin JA; Peng R; Shao X; Smith M; Krishnamurthy R; Selvaraj B; Wang DJJ
    Clin Imaging; 2019; 53():210-220. PubMed ID: 30439588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatial coefficient of variation applied to arterial spin labeling MRI may contribute to predict surgical revascularization outcomes in pediatric moyamoya vasculopathy.
    Tortora D; Scavetta C; Rebella G; Bertamino M; Scala M; Giacomini T; Morana G; Pavanello M; Rossi A; Severino M
    Neuroradiology; 2020 Aug; 62(8):1003-1015. PubMed ID: 32415392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arterial spin-labeling MR imaging in Moyamoya disease compared with clinical assessments and other MR imaging findings.
    Noguchi T; Kawashima M; Nishihara M; Hirai T; Matsushima T; Irie H
    Eur J Radiol; 2013 Dec; 82(12):e840-7. PubMed ID: 24055185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-Dimensional Arterial Spin Labeling for the Evaluation of the Cerebral Hemodynamics in Ischemic and Hemorrhagic Moyamoya Disease.
    Bian H; Zhang L; Wang J
    Cerebrovasc Dis; 2024; 53(3):307-315. PubMed ID: 37722371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can combined high-resolution vessel wall imaging and multiple post-labeling delay 3D pseudo-continuous arterial spin labeling differentiate moyamoya disease from atherosclerotic moyamoya syndrome?
    Guo Y; Dou W; Wang X; Wang X; Mao H; Chen K
    Eur J Radiol; 2023 Dec; 169():111184. PubMed ID: 37931375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of ASL and DSC perfusion methods in the evaluation of response to treatment in patients with a history of treatment for malignant brain tumor.
    Bayraktar ES; Duygulu G; Çetinoğlu YK; Gelal MF; Apaydın M; Ellidokuz H
    BMC Med Imaging; 2024 Mar; 24(1):70. PubMed ID: 38519901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-contrast hemodynamic imaging of Moyamoya disease with MR fingerprinting ASL: A feasibility study.
    Su P; Liu P; Pinho MC; Thomas BP; Qiao Y; Huang J; Welch BG; Lu H
    Magn Reson Imaging; 2022 May; 88():116-122. PubMed ID: 35183659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of MR mTI-ASL and DSC-PWI in evaluating cerebral hemodynamics of patients with Moyamoya disease.
    Zhang J; Xia C; Liu Y; Qian W; Peng W; Liu K; Li L; Zhao F; Li Z
    Medicine (Baltimore); 2018 Oct; 97(41):e12768. PubMed ID: 30313089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arterial spin labelling MRI for assessment of cerebral perfusion in children with moyamoya disease: comparison with dynamic susceptibility contrast MRI.
    Goetti R; O'Gorman R; Khan N; Kellenberger CJ; Scheer I
    Neuroradiology; 2013 May; 55(5):639-47. PubMed ID: 23404242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perfusion measurement in brain gliomas using velocity-selective arterial spin labeling: comparison with pseudo-continuous arterial spin labeling and dynamic susceptibility contrast MRI.
    Qu Y; Kong D; Wen H; Ou X; Rui Q; Wang X; Lin DD; Qin Q; Wen Z
    Eur Radiol; 2022 May; 32(5):2976-2987. PubMed ID: 35066634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.